9 ms·
I don't know if the field is underfunded. What I'd say is that the area is very risky (few ideas really pan out), there are lots of powerful incumbents who wan
by dekhn 6y ago
I don't know if the field is underfunded. What I'd say is that the area is very risky (few ideas really pan out), there are lots of powerful incumbents who want to retain the many-billion-$ revenue streams, and it's very costly to test. But I also see people wasting huge amount of money chasing ideas that really would be better handled with shotgunning (the tech VCs I used work with said "why would I want to invest $20M in a biotech that fails after 20 years, when i can invest $1M in 20 tech startups and one of them will make $1B in 2-3 years?").
It's not clear to me that investing more money helps, either. For example, the NIH doubled its budget during the Clinton era, leading to far higher numbers of grad students being trained than there were positions (prof, etc) in their fields. So there was a glut, super-high competition for a limited number of spaces, and many people dropped out of the race to be a prof and instead went to be ML/data science people at ads firms.